By Martin O'Sullivan ( April 12, 2017, 2:49 PM EDT) -- A proposed class of Investors in Tokai Pharmaceuticals Inc. on Tuesday hit the drugmaker with a suit in Massachusetts federal court, alleging shortcomings in the proxy statement surrounding a deal in which shareholders of Otic Pharma Ltd. would become Tokai's majority owner....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.